Biomarin Pharmaceutical Inc (BMRN)
Days of sales outstanding (DSO)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 3.92 | 3.58 | 3.99 | 4.32 | 3.54 | 3.74 | 3.88 | 3.82 | 4.04 | 3.66 | 3.63 | 4.54 | 4.79 | 4.10 | 4.37 | 4.94 | 4.93 | 4.52 | 4.66 | 4.15 | |
| DSO | days | 93.23 | 101.97 | 91.45 | 84.48 | 103.10 | 97.47 | 94.09 | 95.61 | 90.44 | 99.68 | 100.43 | 80.33 | 76.26 | 89.07 | 83.53 | 73.82 | 74.03 | 80.83 | 78.39 | 87.96 |
September 30, 2025 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 3.92
= 93.23
Peer comparison
Sep 30, 2025
Company name
Symbol
DSO
Biomarin Pharmaceutical Inc
BMRN
93.23
Arrowhead Pharmaceuticals Inc
ARWR
3.00
Regeneron Pharmaceuticals Inc
REGN
145.69